Circulating miRNAs in Ageing and Ageing-Related Diseases

Hwa Jin Jung^a,
Yousin Suh^{a, b
, ,}

a.
Department of Genetics and Medicine, Albert Einstein College of Medicine, Bronx, NY 11363, USA
b.
Ageing Research Institute, Guangdong Medical College, Dongguan 523808, China

More Information

Corresponding author: E-mail address: yousin.suh@einstein.yu.edu (Yousin Suh)

摘要

- /
- /
- /
Abstract: MicroRNAs (miRNAs) are small non-coding RNAs that negatively regulate gene expression at the post-transcriptional level. They are involved in important biological processes including development, homeostasis, and ageing. Recently, extracellular miRNAs have been discovered in the bloodstream and bodily fluids. These miRNAs are shown to be secreted and circulating in microvesicles (MVs), or in complex with other factors such as RNA-binding proteins and high-density lipoprotein (HDL) particles. These cell-free, circulating miRNAs can be taken into and function as negative regulators of target genes in recipient cells. Here we review the biogenesis and uptake of circulating miRNAs as well as their profiles in ageing and ageing-related diseases. We discuss the emerging role of circulating miRNAs as biomarkers and therapeutic targets.
- Circulating miRNAs /
- Ageing /
- Ageing-related disease /
- Biomarkers

HTML全文

参考文献(46)

[1]	Akao, Y., Iio, A., Itoh, T. et al. Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages Mol. Ther., 19 (2011),pp. 395-399
[2]	Alexandrov, P.N., Dua, P., Hill, J.M. et al. microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF) Int. J. Biochem. Mol. Biol., 3 (2012),pp. 365-373
[3]	Arroyo, J.D., Chevillet, J.R., Kroh, E.M. et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma Proc. Natl. Acad. Sci. USA, 108 (2011),pp. 5003-5008
[4]	Baj-Krzyworzeka, M., Szatanek, R., Weglarczyk, K. et al. Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes Cancer Immunol. Immunother., 55 (2006),pp. 808-818
[5]	Bonafe, M., Barbieri, M., Marchegiani, F. et al. Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: cues for an evolutionarily conserved mechanism of life span control J. Clin. Endocrinol. Metab., 88 (2003),pp. 3299-3304
[6]	Cevenini, E., Bellavista, E., Tieri, P. et al. Systems biology and longevity: an emerging approach to identify innovative anti-aging targets and strategies Curr. Pharm. Des., 16 (2010),pp. 802-813
[7]	Chen, T.S., Lai, R.C., Lee, M.M. et al. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs Nucleic Acids Res., 38 (2010),pp. 215-224
[8]	Cheng, Y., Tan, N., Yang, J. et al. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction Clin. Sci. (Lond), 119 (2010),pp. 87-95
[9]	Cogswell, J.P., Ward, J., Taylor, I.A. et al. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways J. Alzheimers Dis., 14 (2008),pp. 27-41
[10]	Collino, F., Deregibus, M.C., Bruno, S. et al. Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs PLoS ONE, 5 (2010),p. e11803
[11]	Cortez, M.A., Calin, G.A. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases Expert Opin. Biol. Ther., 9 (2009),pp. 703-711
[12]	Creemers, E.E., Tijsen, A.J., Pinto, Y.M. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ. Res., 110 (2012),pp. 483-495
[13]	D'Alessandra, Y., Devanna, P., Limana, F. et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction Eur. Heart J., 31 (2010),pp. 2765-2773
[14]	Dhahbi, J.M., Spindler, S.R., Atamna, H. et al. Deep sequencing identifies circulating mouse miRNAs that are functionally implicated in manifestations of aging and responsive to calorie restriction Aging (Albany NY), 5 (2013),pp. 130-141
[15]	Fabbri, M. TLRs as miRNA receptors Cancer Res., 72 (2012),pp. 6333-6337
[16]	Fichtlscherer, S., De Rosa, S., Fox, H. et al. Circulating microRNAs in patients with coronary artery disease Circ. Res., 107 (2010),pp. 677-684
[17]	Geekiyanage, H., Chan, C. MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid beta, novel targets in sporadic Alzheimer's disease J. Neurosci., 31 (2011),pp. 14820-14830
[18]	Geekiyanage, H., Jicha, G.A., Nelson, P.T. et al. Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease Exp. Neurol., 235 (2012),pp. 491-496
[19]	Hunter, M.P., Ismail, N., Zhang, X. et al. Detection of microRNA expression in human peripheral blood microvesicles PLoS ONE, 3 (2008),p. e3694
[20]	Iguchi, H., Kosaka, N., Ochiya, T. Secretory microRNAs as a versatile communication tool Commun. Integr. Biol., 3 (2010),pp. 478-481
[21]	Iorio, M.V., Visone, R., Di Leva, G. et al. MicroRNA signatures in human ovarian cancer Cancer Res., 67 (2007),pp. 8699-8707
[22]	Ji, X., Takahashi, R., Hiura, Y. et al. Plasma miR-208 as a biomarker of myocardial injury Clin. Chem., 55 (2009),pp. 1944-1949
[23]	Jung, H.J., Suh, Y. MicroRNA in aging: from discovery to biology Curr. Genomics, 13 (2012),pp. 548-557
[24]	Karolina, D.S., Tavintharan, S., Armugam, A. et al. Circulating miRNA profiles in patients with metabolic syndrome J. Clin. Endocrinol. Metab., 97 (2012),pp. E2271-E2276
[25]	Kong, L., Zhu, J., Han, W. et al. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study Acta Diabetol., 48 (2011),pp. 61-69
[26]	Kosaka, N., Iguchi, H., Yoshioka, Y. et al. Secretory mechanisms and intercellular transfer of microRNAs in living cells J. Biol. Chem., 285 (2010),pp. 17442-17452
[27]	Li, X., Khanna, A., Li, N. et al. Circulatory miR34a as an RNAbased, noninvasive biomarker for brain aging Aging (Albany NY), 3 (2011),pp. 985-1002
[28]	Llave, C., Xie, Z., Kasschau, K.D. et al. Science, 297 (2002),pp. 2053-2056
[29]	Lukiw, W.J., Alexandrov, P.N. Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain Mol. Neurobiol., 46 (2012),pp. 11-19
[30]	Norata, G.D., Sala, F., Catapano, A.L. et al. MicroRNAs and lipoproteins: a connection beyond atherosclerosis? Atherosclerosis, 227 (2013),pp. 209-215
[31]	Noren Hooten, N., Fitzpatrick, M., , De, S. et al. Age-related changes in microRNA levels in serum Aging (Albany NY), 5 (2013),pp. 725-740
[32]	Olivieri, F., Antonicelli, R., Lorenzi, M. et al. Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction Int. J. Cardiol., 167 (2013),pp. 531-536
[33]	Olivieri, F., Spazzafumo, L., Santini, G. et al. Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging Mech. Ageing Dev., 133 (2012),pp. 675-685
[34]	Skog, J., Wurdinger, T., van Rijn, S. et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers Nat. Cell Biol., 10 (2008),pp. 1470-1476
[35]	Tan, L., Yu, J.T., Liu, Q.Y. et al. Circulating miR-125b as a biomarker of Alzheimer's disease J. Neurol. Sci., 336 (2014),pp. 52-56
[36]	Taylor, D.D., Gercel-Taylor, C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer Gynecol. Oncol., 110 (2008),pp. 13-21
[37]	Turchinovich, A., Weiz, L., Langheinz, A. et al. Characterization of extracellular circulating microRNA Nucleic Acids Res., 39 (2011),pp. 7223-7233
[38]	Valadi, H., Ekstrom, K., Bossios, A. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells Nat. Cell Biol., 9 (2007),pp. 654-659
[39]	Vickers, K.C., Palmisano, B.T., Shoucri, B.M. et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins Nat. Cell Biol., 13 (2011),pp. 423-433
[40]	Wang, G.K., Zhu, J.Q., Zhang, J.T. et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans Eur. Heart J., 31 (2010),pp. 659-666
[41]	Zampetaki, A., Kiechl, S., Drozdov, I. et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes Circ. Res., 107 (2010),pp. 810-817
[42]	Zampetaki, A., Willeit, P., Drozdov, I. et al. Profiling of circulating microRNAs: from single biomarkers to re-wired networks Cardiovasc. Res., 93 (2012),pp. 555-562
[43]	Zernecke, A., Bidzhekov, K., Noels, H. et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection Sci. Signal., 2 (2009),p. ra81
[44]	Zernecke, A., Bot, I., Djalali-Talab, Y. et al. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis Circ. Res., 102 (2008),pp. 209-217
[45]	Zernecke, A., Schober, A., Bot, I. et al. SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells Circ. Res., 96 (2005),pp. 784-791
[46]	Zhang, Y., Liu, D., Chen, X. et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration Mol. Cell, 39 (2010),pp. 133-144